News | October 13, 2010

New Human Study Uses Robotic Catheter Guidance System

October 13, 2010 – Human trials commenced using a catheter guidance control and imaging (CGCI) system on patients with arrhythmias.

Both studies are being conducted at General Universitario La Paz in Madrid. The initial study will consist of 20 patients in which a highly detailed map of the heart will be created using the Magnetecs Corp. CGCI system’s magnetically guided catheter. The mapping study is expected to be completed by the end of 2010. It will be followed by a study of 40 patients in which mapping and ablation procedures will be conducted using the CGCI system. The second study is expected to be completed in the second quarter of 2011.

CGCI uses eight electromagnets to guide a magnetically tipped catheter, enabling a physician to precisely and consistently control surgical tools in highly dynamic or previously inaccessible environments while enhancing both the physician’s dexterity and the patient’s safety.

Magnetecs expects this study to lead to a CE mark application for commercialization in Europe planned for the first half of 2011. Additional human studies for ablation are expected to lead to approval of the CGCI system for therapeutic procedures used to correct heart arrhythmias.

Studies in Europe and the United States will look to receive FDA 510(k) certification. Magnetecs is currently in the initial stages of planning human studies in the United States at Mount Sinai Medical Center in New York City and in the United Kingdom at St. Mary’s Hospital in London.

For more information: www.magnetecs.com

Related Content

Sponsored Content | Videos | Angiography| June 22, 2017
Shimadzu Medical Systems highlighted new features of its Trinias Interventional X-ray line at the America College of
3d printing can aid procedural navigation in transcatheter tricuspid procedures
News | 3-D Printing| June 15, 2017
June 15, 2017 – Structural heart interventions are increasingly applied in patients with severe tricuspid regurgitati
Sponsored Content | Videos | Cardiovascular Ultrasound| June 15, 2017
Madhav Swaminathan, M.D., FASC, FAHA, clinical director of cardiothoracic anesthesiology, at Duke Univer
Large Multicenter Study Shows High Success Rate for Robotic PCI Procedures, SCAI, Corindus CorPath 200
News | Robotic Systems| May 16, 2017
The largest real-world study of robotic percutaneous coronary intervention (PCI) demonstrated clinical and technical...
Robotic-Assisted PCI With CorPath GRX Broadcast Live at TCT Asia-Pacific Summit
News | Robotic Systems| May 01, 2017
Corindus Vascular Robotics Inc. announced that Fu Wai Hospital in China performed and broadcast live a percutaneous...
Clinical Study Validates Efficiencies of Stereotaxis Niobe ES System Over Niobe II System
News | Robotic Systems| April 24, 2017
A recent study conducted at Centre Hospitalier Universitaire (CHU) of Saint-Étienne, France validated the advantages of...
Corindus Announces First Robotic-Assisted PCI Procedures Performed in Asia Using CorPath GRX System
News | Robotic Systems| April 12, 2017
Corindus Vascular Robotics Inc. announced that the first robotic-assisted percutaneous coronary intervention (PCI)...
iFR, iFR vs. FFR, ACC late breaking trial, iFR-SWEDEHEART, DEFINE-FLAIR, Justin E. Davies,

Matthias Götberg, principal investigator for the iFR-SWEDEHEART study, and Justin E. Davies, lead investigator for the DEFINE-FLAIR trial, share key points of their study with DAIC editor Dave Fornell at ACC.17. The trials showed iFR is equal in outcomes to FFR in assessing coronary lesions. 

Feature | FFR Catheters| March 20, 2017
March 20, 2017 — For patients experiencing angina (chest pain) or a heart attack, instantaneous wave-free ratio (iFR)
Sponsored Content | Videos | HIMSS| March 10, 2017
ITN Editor Dave Fornell takes a tour of some of the most innovative new technology that was displayed on the expo flo
Overlay Init